Spinal muscular atrophy trials in Belgium
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- Where
- Gent, Leuven, Liège
- Age
- Up to 17 years
- People
- 30 worldwide
- Run by
- Scholar Rock Inc.
See details and how to join2024-520130-29-00 · EU 2024-520130-29-00 - No phaseTaking peopleSMAdult - Monitoring of Movement on Spinal Muscular Atrophy
- Where
- Liège
- Age
- 15 years and over
- People
- 60
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT07894185 - Phase 3Taking peopleA Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Where
- Gent
- Age
- 0 days to 7 months
- People
- 42 worldwide
- Run by
- Biogen
See details and how to joinNCT07444450 · EU 2025-523857-32-00 - Phase 2Taking peopleA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- Where
- Ghent, Leuven, Liège
- Age
- Up to 2 years
- People
- 52 worldwide
- Run by
- Scholar Rock, Inc.
See details and how to joinNCT07047144 - No phaseTaking peopleActive NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening
- Where
- Liège
- Age
- 4 months and over
- People
- 100
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT07286565